Suppr超能文献

溶酶体贮积症中的常见和不常见的致病级联反应。

Common and uncommon pathogenic cascades in lysosomal storage diseases.

机构信息

From the Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.

出版信息

J Biol Chem. 2010 Jul 2;285(27):20423-7. doi: 10.1074/jbc.R110.134452. Epub 2010 Apr 29.

Abstract

Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered calcium homeostasis, oxidative stress, inflammation, altered lipid trafficking, autophagy, endoplasmic reticulum stress, and autoimmune responses. Some of these pathways are common to many LSDs, whereas others are only altered in a subset of LSDs. We now review how these cascades impact upon LSD pathology and suggest how intervention in the pathways may lead to novel therapeutic approaches.

摘要

溶酶体贮积症(LSDs)已知约有 50 种,是由溶酶体蛋白活性缺陷引起的,导致未代谢的底物积累。结果,多种致病级联反应被激活,如钙稳态改变、氧化应激、炎症、脂质转运改变、自噬、内质网应激和自身免疫反应。这些途径中的一些在许多 LSD 中是共同的,而另一些则仅在 LSD 的亚组中改变。我们现在回顾这些级联反应如何影响 LSD 病理学,并提出干预这些途径可能导致新的治疗方法。

相似文献

1
Common and uncommon pathogenic cascades in lysosomal storage diseases.
J Biol Chem. 2010 Jul 2;285(27):20423-7. doi: 10.1074/jbc.R110.134452. Epub 2010 Apr 29.
2
The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases.
Neurosci Lett. 2019 Apr 1;697:10-16. doi: 10.1016/j.neulet.2018.04.049. Epub 2018 Apr 25.
3
Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
Trends Mol Med. 2017 Feb;23(2):116-134. doi: 10.1016/j.molmed.2016.12.003. Epub 2017 Jan 19.
5
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Mol Pharm. 2016 Feb 1;13(2):357-368. doi: 10.1021/acs.molpharmaceut.5b00542. Epub 2016 Jan 11.
6
Lysosomal positioning diseases: beyond substrate storage.
Open Biol. 2022 Oct;12(10):220155. doi: 10.1098/rsob.220155. Epub 2022 Oct 26.
7
SnapShot: Lysosomal Storage Diseases.
Cell. 2020 Feb 6;180(3):602-602.e1. doi: 10.1016/j.cell.2020.01.017.
8
Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases.
J Cell Sci. 2019 Jan 16;132(2):jcs221739. doi: 10.1242/jcs.221739.
9
Autophagy, mitochondria and cell death in lysosomal storage diseases.
Autophagy. 2007 May-Jun;3(3):259-62. doi: 10.4161/auto.3906. Epub 2007 May 23.
10
Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.
Stem Cells Dev. 2022 May;31(9-10):221-238. doi: 10.1089/scd.2021.0304. Epub 2022 Apr 27.

引用本文的文献

1
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression.
Int J Mol Sci. 2025 Jul 22;26(15):7054. doi: 10.3390/ijms26157054.
3
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome.
Mol Neurodegener. 2025 Aug 6;20(1):89. doi: 10.1186/s13024-025-00880-7.
4
Microglia-neuron crosstalk through Hex-GM2-MGL2 maintains brain homeostasis.
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09477-y.
5
Clinical, genotypic, and neuropsychological profile in a series of patients with Niemann-Pick type C disease.
Front Neurol. 2025 Feb 26;16:1542310. doi: 10.3389/fneur.2025.1542310. eCollection 2025.
9
Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study.
J Mol Med (Berl). 2025 Feb;103(2):187-203. doi: 10.1007/s00109-024-02512-x. Epub 2024 Dec 30.
10
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications.
Front Cardiovasc Med. 2024 Jun 12;11:1420067. doi: 10.3389/fcvm.2024.1420067. eCollection 2024.

本文引用的文献

1
Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
Traffic. 2010 Apr;11(4):419-28. doi: 10.1111/j.1600-0854.2010.01032.x. Epub 2010 Jan 6.
3
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy.
Brain Res. 2009 Dec 1;1300:146-58. doi: 10.1016/j.brainres.2009.09.017. Epub 2009 Sep 11.
4
Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1.
Neurobiol Dis. 2009 Nov;36(2):242-51. doi: 10.1016/j.nbd.2009.07.010. Epub 2009 Jul 24.
5
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.
Blood. 2009 Oct 8;114(15):3181-90. doi: 10.1182/blood-2009-02-205708. Epub 2009 Jul 8.
6
Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis.
Brain Res. 2009 Jul 7;1279:99-108. doi: 10.1016/j.brainres.2009.03.071. Epub 2009 May 3.
7
Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells.
J Clin Neurosci. 2009 Jul;16(7):954-9. doi: 10.1016/j.jocn.2008.09.020. Epub 2009 Apr 1.
8
Microglial physiology: unique stimuli, specialized responses.
Annu Rev Immunol. 2009;27:119-45. doi: 10.1146/annurev.immunol.021908.132528.
9
No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.
Hum Mol Genet. 2009 Apr 15;18(8):1482-8. doi: 10.1093/hmg/ddp061. Epub 2009 Feb 3.
10
Lysosomal disorders: from storage to cellular damage.
Biochim Biophys Acta. 2009 Apr;1793(4):684-96. doi: 10.1016/j.bbamcr.2008.12.001. Epub 2008 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验